Literature DB >> 10957850

Meibomian gland status comparison between active duty personnel and U.S. veterans.

S Stanek1.   

Abstract

PURPOSE: To evaluate the lid and meibomian gland status of active duty forces (ADF) and U.S. veterans (USV) to compare the prevalence of lid dysfunction and disease in each population.
METHODS: One examiner observed 113 consecutive patients in both groups during a 2-week period at two federal service optometry clinics. All eyes were graded with regard to negative findings (or normal), meibomian gland dysfunction (MGD), and/or meibomitis from an established criterion.
RESULTS: 90.3% of ADF had normal lid findings, 5.3% of ADF had MGD (all contact lens patients), and 4.4% of ADF had meibomitis; 28.9% of USV had normal findings, and 71.1% of USV had MGD or meibomitis (no patients wore contact lenses).
CONCLUSION: Our findings reveal that a definite difference exists between ADF personnel and USV in eyelid physiology and pathophysiology. This difference should be noted by the clinician who evaluates such patients. This will affect the differential diagnosis of ocular symptomatology in the contact lens and non-contact lens patient.

Entities:  

Mesh:

Year:  2000        PMID: 10957850

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  8 in total

1.  The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy.

Authors:  Yukihiro Matsumoto; Yuta Shigeno; Enrique Adan Sato; Osama M A Ibrahim; Megumi Saiki; Kazuno Negishi; Yoko Ogawa; Murat Dogru; Kazuo Tsubota
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-20       Impact factor: 3.117

Review 2.  The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD.

Authors:  Debra A Schaumberg; Jason J Nichols; Eric B Papas; Louis Tong; Miki Uchino; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

3.  In vivo confocal microscopy classification in the diagnosis of meibomian gland dysfunction.

Authors:  Matthieu Randon; Vittoria Aragno; Rachid Abbas; Hong Liang; Antoine Labbé; Christophe Baudouin
Journal:  Eye (Lond)       Date:  2018-12-12       Impact factor: 3.775

4.  A Simple Novel Technique of Infrared Meibography by Means of Spectral-Domain Optical Coherence Tomography: A Cross-Sectional Clinical Study.

Authors:  Pietro Emanuele Napoli; Franco Coronella; Giovanni Maria Satta; Claudio Iovino; Raffaele Sanna; Maurizio Fossarello
Journal:  PLoS One       Date:  2016-10-31       Impact factor: 3.240

Review 5.  Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction.

Authors:  Christophe Baudouin; Elisabeth M Messmer; Pasquale Aragona; Gerd Geerling; Yonca A Akova; José Benítez-del-Castillo; Kostas G Boboridis; Jesús Merayo-Lloves; Maurizio Rolando; Marc Labetoulle
Journal:  Br J Ophthalmol       Date:  2016-01-18       Impact factor: 4.638

6.  In vivo Confocal Microscopy Evaluation of Meibomian Gland Dysfunction in Dry Eye Patients with Different Symptoms.

Authors:  Hui Zhao; Jing-Yao Chen; Yu-Qian Wang; Zhi-Rong Lin; Shen Wang
Journal:  Chin Med J (Engl)       Date:  2016-11-05       Impact factor: 2.628

7.  The application of in vivo laser confocal microscopy to the diagnosis and evaluation of meibomian gland dysfunction.

Authors:  Yukihiro Matsumoto; Enrique Adan Sato; Osama M A Ibrahim; Murat Dogru; Kazuo Tsubota
Journal:  Mol Vis       Date:  2008-07-09       Impact factor: 2.367

Review 8.  In Vivo Laser Scanning Confocal Microscopy of Human Meibomian Glands in Aging and Ocular Surface Diseases.

Authors:  Vincenzo Fasanella; Luca Agnifili; Rodolfo Mastropasqua; Lorenza Brescia; Federico Di Staso; Marco Ciancaglini; Leonardo Mastropasqua
Journal:  Biomed Res Int       Date:  2016-03-07       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.